Charles Schwab Investment Management Inc Pulmonx Corp Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 301,372 shares of LUNG stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
301,372
Previous 289,357
4.15%
Holding current value
$1.91 Million
Previous $3.69 Million
24.29%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding LUNG
# of Institutions
124Shares Held
30.8MCall Options Held
1.2KPut Options Held
1.2K-
Primecap Management CO Pasadena, CA5.74MShares$36.4 Million0.04% of portfolio
-
Black Rock Inc. New York, NY3.04MShares$19.3 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.72MShares$17.2 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.65MShares$16.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$13.2 Million0.0% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $236M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...